Etrolizumab
Etrolizumab (rhuMAb Beta7), a gut-selective anti-β7 integrin monoclonal antibody, targets the β7 subunit of α4β7 and αEβ7 integrins specifically, demonstrating affinity with K i values of 18 nM for Human α4β7 and 1800 pM for Human αEβ7-293. It is utilized in the research of inflammatory bowel disease (IBD) .
Product Specifications
CAS Number
1044758-60-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6132418-01 0.1 mL
MTMR14 (Myotubularin-related Protein 14, HCV NS5A-transactivated Protein 4 Splice Variant A-binding Protein 1, NS5ATP4ABP1, hJumpy, C3orf29) (AP)
Ask
View Details MBS6132418-02 5x 0.1 mL
MTMR14 (Myotubularin-related Protein 14, HCV NS5A-transactivated Protein 4 Splice Variant A-binding Protein 1, NS5ATP4ABP1, hJumpy, C3orf29) (AP)
Ask
View Details